Prime Medicine, Inc. Earnings Per Share Diluted

Quick Answer

Prime Medicine, Inc. reported Earnings Per Share Diluted of $1.35 (loss) per share for the year ending 2025.

  • Prime Medicine, Inc. showed an increase of +18.2% in Earnings Per Share Diluted from 2024 to 2025.
  • This data is from Prime Medicine, Inc.'s annual report (Form 10-K), filed with the SEC on March 3, 2026.
  • XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 6 years of available data (2020 to 2025), Prime Medicine, Inc.'s Earnings Per Share Diluted has grown by 29.3%.
  • Historical annual values: Fiscal year 2025: $1.35 (loss) per share | Fiscal year 2024: $1.65 (loss) per share | Fiscal year 2023: $2.18 (loss) per share | Fiscal year 2022: $4.19 (loss) per share | Fiscal year 2021: $14.19 (loss) per share | Fiscal year 2020: $1.91 (loss) per share.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: